Message #26 From:
Jason Date: April 14, 2009 10:21:08 AM
DNDN stock Up %182
In a study it was found that DNDN's Provenge significantly prolonged the life of men with prostate cancer. The news drove the share price of DNDN almost 200% higher. An exciting day for DNDN shareholders and Dendreon corp!
